Chudova Darya 4

4 · Guardant Health, Inc. · Filed Oct 2, 2025

Form 4

Period: 2025-10-01

Chief Technology Officer

Transactions

Exercise/Conversion
Common Stock
2025-10-01+1,668→ 84,456 total
Exercise/Conversion
Restricted Stock Units
2025-10-01−1,339→ 5,357 total
Exercise: $0.00→ Common Stock (1,339 underlying)
Exercise/Conversion
Restricted Stock Units
2025-10-01−13,097→ 26,592 total
Exercise: $0.00→ Common Stock (13,097 underlying)
Tax Payment
Common Stock
2025-10-01$62.65/sh−8,163$511,412→ 89,390 total
Exercise/Conversion
Common Stock
2025-10-01+1,339→ 82,788 total
Exercise/Conversion
Restricted Stock Units
2025-10-01−1,668→ 6,669 total
Exercise: $0.00→ Common Stock (1,668 underlying)
Exercise/Conversion
Common Stock
2025-10-01+13,097→ 97,553 total

Footnotes (5)

[F1]These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
[F2]This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter.
[F3]Not applicable for Restricted Stock Units.
[F4]This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
[F5]This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vests on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.

Documents

1 file